Do You Want to Break Up With Your Makeup?

Sponsored Post



If you're like me, you start your makeup routine by assessing your skin and deciding how much you'll need to cover up that day. Because I have rosacea, that can vary quite a bit day to day. My skin can be red and inflamed, requiring layers of green corrector, BB Cream or foundation, concealer and powder. All to look like I have normal skin! I have the routine down, so it usually doesn't take more than a few minutes, but I live for those days that I only need a small amount of cover-up for my under eye circles!

Not everyone with rosacea has this routine every morning, but if you have rosacea you're much more likely to be covering up every morning than women who don't have rosacea, 67% of women with rosacea wear makeup to work, only 36% of women without rosacea wear makeup to work.

The main reason I cover-up is redness, which Mirvaso® (brimonidine) topical gel, 0.33%* was created to treat. It will combat persistent facial redness, but you'll need a prescription from your doctor to get it.

Mirvaso has created a website to provide skin care and rosacea redness information, and they're even holding an amazing sweepstakes for a chance to win a trip to the Emmys! I found the skin care tips from NYC dermatologist Dr. Doris Day to be especially helpful.

Check out the Mirvaso Break Up With Your Makeup Website
Sponsored Post
The post is sponsored by Galderma Laboratories, L.P.

Mirvaso is a prescription drug and you'll need to see your doctor (remember, I'm a doctor, but I'm not your doctor!) to discuss whether it is a good option for you.

Important Safety Information Indication: Mirvaso® (brimonidine) topical gel, 0.33%* is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older. Adverse Events: In clinical trials, the most common adverse reactions (≥1%) included erythema, flushing, skin burning sensation and contact dermatitis. Warnings/Precautions: Mirvaso Gel should be used with caution in patients with depression, cerebral or coronary insufficiency, Raynaud's phenomenon, orthostatic hypotension, thromboangiitis obliterans, scleroderma, or Sjögren’s syndrome. Alpha-2 adrenergic agents can lower blood pressure. Mirvaso Gel should be used with caution in patients with severe or unstable or uncontrolled cardiovascular disease. Serious adverse reactions following accidental ingestion of Mirvaso Gel by children have been reported. Keep Mirvaso Gel out of reach of children. Not for oral, ophthalmic, or intravaginal use.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

*Each gram of gel contains 5 mg of brimonidine tartrate, equivalent to 3.3 mg of brimonidine free base.